FDA approves ASD diagnostic tool
Digital health company EarliTec Diagnostics Inc. announced it has received FDA clearance for its evaluation tool to diagnose autism spectrum disorder in children aged 16 to 30 months. According to a press release from EarliTec, EarliPoint Evaluation was granted clearance based on positive results from two studies, a clinical trial as well as a repeatability and reproducibility study, in which